Sep 30, 2022

Arcturus Therapeutics Q3 2022 Earnings Report

Total Revenue
$13.4M
Previous year: $2.44M
+448.6%
EPS
-$1.33
Previous year: -$2.05
-35.1%
Gross Profit
$13.4M
Previous year: $2.44M
+448.6%
Cash and Equivalents
$238M
Previous year: $414M
-42.6%
Free Cash Flow
-$44.6M
Previous year: -$18.4M
+142.1%
Total Assets
$294M
Previous year: $435M
-32.4%

Arcturus Therapeutics

Arcturus Therapeutics